Abstract:Heritable diseases often manifest in a highly tissue specific manner, with different disease loci mediated by genes in distinct tissues or cell types. We propose Tissue Gene Fine-Mapping (TGFM), a fine mapping method that infers the posterior probability (PIP) for each gene tissue pair to mediate a disease locus by analyzing GWAS summary statistics (and in sample LD) and leveraging eQTL data from diverse tissues to build cis predicted expression models; TGFM also assigns PIPs to causal variants that are not mediated by gene expression in assayed genes and tissues. TGFM accounts for both co regulation across genes and tissues and LD between SNPs (generalizing existing fine mapping methods), and incorporates genome wide estimates of each tissues contribution to disease as tissue level priors. TGFM was well calibrated and moderately well powered in simulations; unlike previous methods, TGFM was able to attain correct calibration by modeling uncertainty in cis predicted expression models. We applied TGFM to 45 UK Biobank diseases/traits (average N = 316K) using eQTL data from 38 GTEx tissues. TGFM identified an average of 147 PIP > 0.5 causal genetic elements per disease/trait, of which 11% were gene tissue pairs. Implicated gene tissue pairs were concentrated in known disease critical tissues, and causal genes were strongly enriched in disease relevant gene sets. Causal gene tissue pairs identified by TGFM recapitulated known biology (e.g., TPO thyroid for Hypothyroidism), but also included biologically plausible novel findings (e.g., SLC20A2 artery aorta for Diastolic blood pressure). Further application of TGFM to single cell eQTL data from 9 cell types in peripheral blood mononuclear cells (PBMC), analyzed jointly with GTEx tissues, identified 30 additional causal gene-PBMC cell type pairs at PIP > 0.5, primarily for autoimmune disease and blood cell traits, including the biologically plausible example of CD52 in classical monocyte cells for Monocyte count. In conclusion, TGFM is a robust and powerful method for fine mapping causal tissues and genes at disease-associated loci.

Fine-mapping causal tissues and genes at disease-associated loci